Show simple item record

dc.contributor.authorMonaghan, Phillip J
dc.contributor.authorKeevil, B
dc.contributor.authorStewart, P
dc.contributor.authorTrainer, Peter J
dc.date.accessioned2014-11-04T10:50:27Z
dc.date.available2014-11-04T10:50:27Z
dc.date.issued2014-10-16
dc.identifier.citationCase for the wider adoption of mass spectrometry-based adrenal steroid testing, and beyond. 2014:20142258 J Clin Endocrinol Metaben
dc.identifier.issn1945-7197
dc.identifier.pmid25322267
dc.identifier.doi10.1210/jc.2014-2258
dc.identifier.urihttp://hdl.handle.net/10541/333688
dc.description.abstractAbstract Not Available.
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to The Journal of clinical endocrinology and metabolismen
dc.titleCase for the wider adoption of mass spectrometry-based adrenal steroid testing, and beyond.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Biochemistry (B.G.K.), University Hospital of South Manchester, Manchester M23 9LT, United Kingdom; Medical School (P.M.S.), University of Leeds, Leeds LS2 9NL, United Kingdom; The Christie Pathology Partnership (P.J.M.), ●●●●; Department of Endocrinology (P.J.T.), The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom; and Centre for Endocrinology & Diabetes (●●●●), Institute of Human Development, University of Manchester, Manchester Academic Health Science Centre, United Kingdom.en
dc.identifier.journalJournal of Clinical Endocrinology and Metabolismen
html.description.abstractAbstract Not Available.


This item appears in the following Collection(s)

Show simple item record